This site is intended for healthcare professionals
  • Home
  • /
  • Guidelines
  • /
  • Cancer of rectum and anus
  • /
  • Anal cancer: ESMO-ESSO-ESTRO Clinical Practice Gui...
Guideline

Anal cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Read time: 1 mins
Last updated:31st Aug 2014

Squamous cell carcinoma of the anus (SCCA) is strongly associated with human papillomavirus (HPV) infection which represents the causative agent in 80%–85% of patients (usually from HPV16 or HPV18 subtypes in Europe) as is its precursor lesion anal intra-epithelial neoplasia (AIN). This ESMO-ESSO-ESTRO Guideline gives information on the incidence and epidemiology, diagnosis, screening, pathology and molecular biology of the disease as well as current treatment options and follow-up.

 

Read full guideline